Baird Medical Set to Showcase Microwave Ablation Innovations at NASIT 2025

Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD), a key player in the field of minimally invasive Microwave Ablation (MWA) technology, is proud to announce its participation in the upcoming 2025 North American Society for Interventional Thyroidology (NASIT) Conference. This prestigious event will take place from January 31 to February 1, 2025, in Washington, D.C.

The NASIT Conference serves as a vital platform for education, research, and collaboration within the realm of thyroid interventions. Baird Medical's invitation to this prominent event underscores its increasing significance and reputation in the arena of microwave ablation. The company aims to leverage this opportunity to engage with leading experts, industry innovators, and potential collaborators from around the world.

Having participated in previous editions, Baird Medical is enthusiastic about resuming discussions focused on the latest breakthroughs in MWA technology and sharing its insights with other professionals in interventional thyroidology. This conference is seen as an ideal occasion for the company not just to present its advancements but also to gain valuable insights into evolving industry trends, further refining its strategic initiatives, and fostering the ongoing innovation that drives growth within global healthcare.

A notable highlight at the conference will be the presentation by Dr. Emad Kandil, a distinguished Professor and the Ellis Hanna Chair in Surgery at Tulane University School of Medicine. Dr. Kandil recently achieved a remarkable milestone, completing 100 MWA procedures. His presentation, set to take place at the Product Theater, will delve into his clinical experiences and offer a unique perspective on the role of MWA in thyroid care.

Baird Medical is firmly committed to advancing minimally invasive technologies and collaborates actively with healthcare professionals to explore innovative solutions for thyroid treatment. The company continues to develop advanced devices that enhance patient care, ensuring that the technologies they provide are both safe and effective.

About Baird Medical

Baird Medical specializes in minimally invasive microwave ablation technology, offering cutting-edge treatment options for various medical conditions, including thyroid nodules, breast disease, uterine fibroids, and liver cancer. Publicly traded on NASDAQ, the company is dedicated to improving patient outcomes through innovative solutions that prioritize precision, efficiency, and safety.

About NASIT

The North American Society for Interventional Thyroidology is the largest multidisciplinary group in the USA dedicated to the specialization of interventional thyroidology. Founded to promote safe practices and the integration of ablative thyroid technologies into clinical routines, NASIT encourages collaboration among specialists and advancements in educational research within this vital field.

Baird Medical looks forward to participating in this important event and continuing its journey towards enhancing the standards of care with innovative medical devices and techniques.